Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMPRSS11BNL (TMPRSS11B N-terminal like) is classified as a pseudogene in humans and does not encode a functional protein. Its sequence is homologous to the protein-coding gene TMPRSS11B but lacks a functional product. There is no evidence it functions as a receptor, enzyme, or any conventional drug target, nor does it have characterized biological activity or relevance as a drug target[3]. Key clarification: *TMPRSS11BNL* is not the same as the functional TMPRSS11B gene (Transmembrane protease, serine 11B), which is a serine protease with tumorigenic roles in lung cancer[1][2]. The pseudogene is genomically related but is not itself a receptor, enzyme, or therapeutic target, and should not be confused with TMPRSS11B. All disease, functional, and drug-targeting information refers to TMPRSS11B, not TMPRSS11BNL[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMPRSS11B N-terminal like (pseudogene) (TMPRSS11BNL).